Managing Pediatric Asthma Exacerbations: The Role of Timely Systemic Corticosteroid Administration in Emergency Care

Luna Antonino1,2, Eva Goossens2,3,4, Josefien van Olmen5

  • 1Laboratory of Experimental Medicine and Pediatrics, Department of Pediatrics, Faculty of Medicine and Health Sciences, University of Antwerp, 2610 Antwerp, Belgium.

PubMed

Insights

Most children with asthma exacerbations in the emergency department do not receive timely systemic corticosteroids (SCS). Delayed SCS administration correlates with longer hospital stays and increased oxygen therapy needs in pediatric asthma patients.

Area of Science:

  • Pediatric Emergency Medicine
  • Respiratory Medicine
  • Clinical Pharmacology

Background:

  • Asthma is a leading chronic respiratory illness in children.
  • Asthma exacerbations (AE) frequently lead to emergency department (ED) visits.
  • Prompt systemic corticosteroids (SCS) administration is crucial for managing moderate to severe AE.

Purpose of the Study:

  • To evaluate the timing of SCS administration in pediatric AE.
  • To correlate SCS timing with length of stay and oxygen therapy duration.
  • To identify predictors of timely SCS administration.

Main Methods:

  • Retrospective, multicenter observational study.
  • Included children under 18 with moderate to severe AE.
  • Data extracted from electronic medical records.

Main Results:

  • Only 28 out of 205 patients received SCS within 60 minutes.
  • Median time to SCS was 169 minutes.
  • Delayed SCS correlated with longer oxygen therapy (r=0.363) and hospital stay (r=0.368).

Conclusions:

  • A significant majority of pediatric AE cases did not receive timely SCS.
  • Delayed SCS administration is linked to poorer outcomes, including extended hospital stay and oxygen support.
  • No patient characteristics predicted timely SCS administration in this cohort.
Abstract

Related Concept Videos

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
247
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
206
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
398
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
261
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
775